BlackRock Japan’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

BlackRock Japan’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Sell	689 -4,024	-85%	-$22.1K	﹤0.01%	1273
2016 Q3	$26K	Sell	4,713 -2,735	-37%	-$18.1K	﹤0.01%	1082
2016 Q2	$52K	Sell	7,448 -681	-8%	-$4.8K	﹤0.01%	992
2016 Q1	$54K	Buy	8,129 +4,630	+132%	+$34.1K	﹤0.01%	1018
2015 Q4	$36K	Buy	3,499 +167	+5%	+$1.94K	﹤0.01%	1082
2015 Q3	$39K	Buy	+3,332	New	+$36.8K	﹤0.01%	1016

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BlackRock Japan's JNP Position: Q4 2016 in Review

BlackRock Japan reduced its Juniper Pharmaceuticals, Inc. Common Stock (JNP) stake by 85% in Q4 2016, selling an estimated $22.1K and leaving 689 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

BlackRock Japan first reported a position in JNP in Q3 2015 and has held it in 6 quarters since. The position peaked at $54K in Q1 2016. 40 funds tracked by Wall St. Rank hold JNP as of Q4 2016.

BlackRock Japan held 689 shares of Juniper Pharmaceuticals, Inc. Common Stock worth $4K as of Q4 2016.
BlackRock Japan sold 4,024 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2016, an estimated $22.1K.
Juniper Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1273 holding.
BlackRock Japan first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2015 and has held it in 6 quarters since.
BlackRock Japan's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $54K in Q1 2016.
40 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.